Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 404-370-8 | CAS number: 126990-35-0 DCPMS; DYNASYLAN 9415; EURENOR 5023; SAN-30; WACKER SILAN CP2-DIMETHOXY; Z-6228
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
In an acute oral toxicity study conducted to the now deleted OECD Test Guideline 401 and in compliance with GLP, the LD50 for dicyclopentyl(dimethoxy)silane (CAS 126990-35-0) was greater than 2000 mg/kg bw in rats (Safepharm Laboratories Ltd., 1995a).
In an acute inhalation study conducted using a protocol similar to OECD Test Guideline 403 and in compliance with GLP, the LC50 for dicyclopentyl(dimethoxy)silane was greater than 22 ppm, as no deaths occurred following a 4-hour exposure to this concentration. This concentration appeared to be the highest attainable under the conditions of this study (DCC, 1993).
In an acute dermal toxicity study conducted according to an EU guideline (EU Method B.3 (Acute Toxicity (Dermal)) and in compliance with GLP, the LD50 for dicyclopentyl(dimethoxy)silane was greater than 2000 mg/kg bw in rats (Huntingdon Research Centre Ltd., 1995b).
Key value for chemical safety assessment
Acute toxicity: via oral route
Link to relevant study records
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 06.07.1995 to 26.07.1995
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 401 (Acute Oral Toxicity)
- GLP compliance:
- yes (incl. QA statement)
- Test type:
- standard acute method
- Limit test:
- yes
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Charles River (UK) Ltd, UK
- Age at study initiation: 5-8 weeks
- Weight at study initiation: Males: 156-186 g; Females: 130-142 g.
- Fasting period before study: yes, overnight
- Housing: Groups of five in polypropylene cages
- Diet (e.g. ad libitum): Ad libitum
- Water (e.g. ad libitum): Ad libitum
- Acclimation period: At least five days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 19-24
- Humidity (%): 47-66
- Air changes (per hr): Approximately 15
- Photoperiod (hrs dark / hrs light): 12/12
IN-LIFE DATES: From: 14.02.1995 to 02.03.1995 - Route of administration:
- oral: gavage
- Vehicle:
- unchanged (no vehicle)
- Details on oral exposure:
- MAXIMUM DOSE VOLUME APPLIED: 2.05 ml/kg
- Doses:
- 2000 mg/kg
- No. of animals per sex per dose:
- 5
- Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations and weighing: The animals were observed for deaths or overt signs of toxicity 0.5, 1, 2 and 4 hours after dosing and subsequently once daily for 14 days. Individual bodyweights were recorded prior to dosing on day 0 and on days 7 and 14.
- Necropsy of survivors performed: yes
- Other examinations performed: macroscopic examination only - Key result
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- > 2 000 mg/kg bw
- Based on:
- test mat.
- Remarks on result:
- other: No deaths
- Mortality:
- No deaths occurred.
- Clinical signs:
- other: None.
- Gross pathology:
- No abnormal findings.
- Other findings:
- None.
- Interpretation of results:
- GHS criteria not met
- Remarks:
- Criteria used for interpretation of results: EU
- Conclusions:
- In an acute oral toxicity study conducted according to the now deleted OECD Test Guideline 401 and in compliance with GLP (Safepharm Laboratories Ltd., 1995), the LD50 for dicyclopentyldimethoxysilane was greater than 2000 mg/kg bw in rats. There were no clinical signs of toxicity, effects on body weight or abnormal macroscopic findings.
Reference
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 2 000 mg/kg bw
Acute toxicity: via inhalation route
Link to relevant study records
- Endpoint:
- acute toxicity: inhalation
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 06.11.1992 to 11.06.1993
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 403 (Acute Inhalation Toxicity)
- Deviations:
- yes
- Remarks:
- Only one dose tested
- GLP compliance:
- yes
- Test type:
- standard acute method
- Limit test:
- no
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: No data
- Age at study initiation: 6-8 weeks
- Weight at study initiation: 155-195 g
- Fasting period before study: No
- Housing: Stainless steel cages
- Diet (e.g. ad libitum): Ad libitum
- Water (e.g. ad libitum): Ad libitum
- Acclimation period: Seven days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22± 2
- Humidity (%): 50± 20
- Air changes (per hr): No data
- Photoperiod (hrs dark / hrs light): 12/12
IN-LIFE DATES: From: 19.11.1992 To: 07.12.1992 - Route of administration:
- inhalation: vapour
- Type of inhalation exposure:
- whole body
- Vehicle:
- air
- Details on inhalation exposure:
- GENERATION OF TEST ATMOSPHERE / CHAMBER DESCRIPTION
- Exposure apparatus and chamber volume: 450 litre stainless steel and glass exposure chambers.
- Method of holding animals in test chamber: None
- Source and rate of air: Ambient filtered with hepa and charcoal filters. 12-15 air changes per hour.
- Treatment of exhaust air: No data
- Temperature, humidity, pressure in air chamber: Recorded every five minutes during the exposure period.
TEST ATMOSPHERE
- Brief description of analytical method used: Chamber concentrations were measured at least once per hour by a Varian 3400 Gas Chromatography.
- Samples taken from breathing zone: No data - Analytical verification of test atmosphere concentrations:
- yes
- Duration of exposure:
- 4 h
- Concentrations:
- Nominal: 33 ppm
Actual: 22 ppm
The saturated vapour concentration is approximately 52 ppm. The target exposure concentration of 30 ppm appears to have been unattainable under the conditions of this study as evidenced by the test substance deposition within the vapour generating and the gas chromatography sampling system. - No. of animals per sex per dose:
- Five
- Control animals:
- yes
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations and weighing: Observed daily during the post-exposure period for clinical signs, mortality, general appearance and any evidence of respiratory, dermal, behavioural, nasal or ocular changes. Animals were weighed on days 1, 8 and 15.
- Necropsy of survivors performed: yes
- Other examinations performed: Gross pathological examination was conducted on all animals. The kidneys were examined microscopically. - Statistics:
- Statistical analyses were conducted on body weights. Data were analysed by a two-sided Welch Trend Test. All tests were conducted at the P≤ 0.05 level of significance.
- Sex:
- male/female
- Dose descriptor:
- LC50
- Effect level:
- > 22 ppm
- Based on:
- test mat.
- Exp. duration:
- 4 h
- Remarks on result:
- other: No deaths.
- Mortality:
- No animals died.
- Clinical signs:
- other: None
- Body weight:
- No effects on body weights.
- Gross pathology:
- Pale kidneys were observed in 9/10 animals.
- Other findings:
- Histopathological examination of pale kidneys did not reveal any correlative microscopic lesions.
- Interpretation of results:
- GHS criteria not met
- Remarks:
- Criteria used for interpretation of results: EU
- Conclusions:
- In an acute inhalation study conducted using a protocol similar to OECD Test Guideline 403 and in compliance with GLP, the LD50 for dicyclopentyl(dimethoxy)silane was greater than 22 ppm, as no deaths occurred following a 4-hour exposure to this concentration. This concentration appeared to be the highest attainable under the conditions of this study.
Reference
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- LC50
- Value:
- 205.52 mg/m³ air
Acute toxicity: via dermal route
Link to relevant study records
- Endpoint:
- acute toxicity: dermal
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 16.02.1995 to 02.03.1995
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.3 (Acute Toxicity (Dermal))
- GLP compliance:
- yes (incl. QA statement)
- Test type:
- standard acute method
- Limit test:
- yes
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Harlan Olac, UK
- Age at study initiation: 7-10 weeks
- Weight at study initiation: 225-290 g
- Fasting period before study: No
- Housing: Individually in metal cages with wire mesh floors
- Diet (e.g. ad libitum): Ad libitum
- Water (e.g. ad libitum): Ad libitum
- Acclimation period: Seven days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22± 3
- Humidity (%): 30-70
- Air changes (per hr): 10-15
- Photoperiod (hrs dark / hrs light): 12/12
IN-LIFE DATES: From: 16.02.1995 To: 02.03.1995 - Type of coverage:
- semiocclusive
- Vehicle:
- unchanged (no vehicle)
- Details on dermal exposure:
- TEST SITE
- Area of exposure: Dorso-lumbar region
- % coverage: Approximately 10%
- Type of wrap if used: Gauze held in place with non-irritating dressing
REMOVAL OF TEST SUBSTANCE
- Washing (if done): yes, with warm water and blotted dry with absorbent paper.
- Time after start of exposure: 24 hours
TEST MATERIAL
- Amount(s) applied (volume or weight with unit): 2.01 ml/kg bw - Duration of exposure:
- 24 hours
- Doses:
- 2000 mg/kg bw
- No. of animals per sex per dose:
- Five
- Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations and weighing: Twice daily for mortality. For clinical effects, animals were observed soon after dosing and at frequent intervals on the day of dosing (Day 1). On subsequent days the animals were observed twice daily. Individual body weights were recorded on Day 1 (prior to dosing), 8 and 15. Individual weekly bodyweight changes and group mean body weights were calculated.
- Necropsy of survivors performed: yes/no
- Other examinations performed: Local dermal effects scored, macroscopic examination - Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- > 2 000 mg/kg bw
- Based on:
- test mat.
- Remarks on result:
- other: No deaths
- Mortality:
- No deaths occurred.
- Clinical signs:
- other: There were no signs of systemic toxicity.
- Gross pathology:
- There were no abnormal findings.
- Other findings:
- Slight erythema (with or without oedema) was noted in one animal following the removal of the dressings and persisting for the following two days. This was accompanied by spot/scab formation in this and one other rat during the study. In addition desquamation (characterised by dryness/sloughing/scaling) was evident in up to four animals during the latter stage of week 1 and resolving in all instances by day 10.
- Interpretation of results:
- GHS criteria not met
- Remarks:
- Criteria used for interpretation of results: EU
- Conclusions:
- In an acute dermal toxicity study conducted to an EU guideline (with a protocol comparable to OECD Test Guideline 402) and in compliacne with GLP, the LD50 for dicyclopentyl(dimethoxy)silane was greater than 2000 mg/kg bw in rats. There were no signs of systemic toxicity, and only mild dermal irritation in a few animals.
Reference
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 2 000 mg/kg bw
Additional information
There are several reliable studies available for oral and dermal routes of exposure. All are of equal quality and conducted in 1995. They all support the key finding that dicyclopentyl(dimethoxy)silane (CAS 126990-35-0) is of low acute toxicity. There is one reliable study for the inhalation route.
In the key acute oral toxicity study conducted according to the now deleted OECD Test Guideline 401 and in compliance with GLP, the LD50 for dicyclopentyl(dimethoxy)silane was greater than 2000 mg/kg bw in rats. There were no clinical signs of toxicity, effects on body weight or abnormal macroscopic findings (Safepharm Laboratories Ltd., 1995a).
In a supporting acute oral toxicity study conducted according to the now deleted OECD Test Guideline 401 and in compliance with GLP, there were no deaths as a result of treatment with dicyclopentyl(dimethoxy)silane. No clinical signs of toxicity, no effect on body weight gain were observed during the observation period. No organ abnormalities were observed at necropsy. The LD50 value was therefore greater than 2000 mg/kg bw in rats (RCC Ltd, 1995a).
In another supporting acute oral toxicity study according to the now deleted OECD Test Guideline 401 and in compliance with GLP, the LD50 for dicyclopentyl(dimethoxy)silane was greater than 2000 mg/kg bw in rats as there were no deaths.
Clinical signs of reaction to treatment included piloerection, abnormal body carriage, abnormal gait and pallor of the extremities, seen in all rats. In addition, lethargy, decreased respiratory rate, partially closed eyelids, increased urine production, increased salivation and gasping/noisy respiration were seen in one or more rats. Recovery was complete in all instances by day 3.
A slightly low bodyweight gain was recorded for two males and one female on day 8, with a similar trend noted for one male on day 15. All other animals achieved satisfactory bodyweight gains throughout the study. Macroscopic examination on day 15 revealed congestion of the thymus in one male. No other abnormalities were noted amongst rats killed on day 15.
In the key acute inhalation study conducted using a protocol similar to OECD Test Guideline 403 and in compliance with GLP, the LC50 for dicyclopentyl(dimethoxy)silane was greater than 22 ppm, as no deaths occurred following a 4-hour exposure to this concentration. This concentration appeared to be the highest attainable under the conditions of this study (DCC, 1993). Pale kidneys were observed in 9/10 animals, however, its associated histopathological examination did not reveal any correlative microscopic lesions.
In the key acute dermal toxicity study conducted to an EU guideline (EU Method B.3 (Acute Toxicity (Dermal)) and in compliance with GLP, the LD50 for dicyclopentyl(dimethoxy)silane was greater than 2000 mg/kg bw in rats. There were no signs of systemic toxicity, and only mild dermal irritation in a few animals. Slight erythema (with or without oedema) was noted in one animal following the removal of the dressings and persisting for the following two days. This was accompanied by spot/scab formation in this and one other rat during the study. In addition, desquamation (characterised by dryness/sloughing/scaling) was evident in up to four animals during the latter stage of week 1 and resolving in all instances by day 10 (Huntingdon Research Centre Ltd., 1995b).
The same results were found in two other supporting studies conducted according to the same OECD Test Guideline 402 and in compliance with GLP (RCC Ltd 1995b., and Safepharm Laboratories Ltd., 1995b).
Justification for classification or non-classification
Based on the available acute toxicity data, dicyclopentyl(dimethoxy)silane is not classified for effects following a single exposure according to Regulation (EC) No 1272/2008.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.